Trial Summary Table

Trial Name	Phase	Start Date	Sponsors	Countries	Population	Candidate(s)	Status	Expected Completion Date
Impact of Immediate Versus South African Recommendations Guided ART Initiation on HIV Incidence (TasP)	Open Label	Tuesday, December 20, 2011		South Africa	Women, Men	TDF/FTC (Truvada)	Ongoing	December 2016
Impacts of universal access to HIV/AIDS care among HIV-positive IDUs	Other	Tuesday, January 31, 2006	British Columbia Ministry of Health, NIDA	Canada	Injecting drug users, HIV positive		Completed	December 2013
Integrated care clinics for IDUs in India: A cluster randomized trial	III	Monday, January 31, 2011	NIDA, Johns Hopkins University	India	Women, Men, Injecting drug users, HIV positive		Ongoing	December 2016
Interventions to Decrease HIV Infectiousness	Open Label	Sunday, January 31, 2010	NIAID	Uganda	Women, Men, HIV positive		Completed	December 2013
Kakyerere Community Health Campaign	Other			Uganda	HIV positive		Ongoing
Karonga Prevention Study	Open Label	Wednesday, March 19, 2014		Malawi			Ongoing	March 2014
LINK LA	Other	Tuesday, January 31, 2012	UCLA, NIH	United States of America	Men			April 2014
LINK4HEALTH	Open Label	Saturday, August 31, 2013	Columbia University, NIH, NIAID, CDC, & New York University	Swaziland	HIV positive, Men, Women		Completed	October 2021
Medecins Sans Frontieres TasP	Open Label	Thursday, April 3, 2014	MSF, South Africa DoH		Women, Men, HIV positive		Ongoing
MK-8527-004	Open Label, I	Tuesday, September 20, 2022	Merck Sharp & Dohme LLC		Men, Women	MK-8527	Planned	September 2022

You are here